Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 3
2016 2
2017 7
2019 6
2020 5
2021 4
2022 3
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
Østergaard M, van Vollenhoven RF, Rudin A, Hetland ML, Heiberg MS, Nordström DC, Nurmohamed MT, Gudbjornsson B, Ørnbjerg LM, Bøyesen P, Lend K, Hørslev-Petersen K, Uhlig T, Sokka T, Grondal G, Krabbe S, Lindqvist J, Gjertsson I, Glinatsi D, Kapetanovic MC, Aga AB, Faustini F, Parmanne P, Lorenzen T, Giovanni C, Back J, Hendricks O, Vedder D, Rannio T, Grenholm E, Ljoså MK, Brodin E, Lindegaard H, Söderbergh A, Rizk M, Kastbom A, Larsson P, Uhrenholt L, Just SA, Stevens DJ, Bay Laurbjerg T, Bakland G, Olsen IC, Haavardsholm EA, Lampa J; NORD-STAR study group. Østergaard M, et al. Among authors: glinatsi d. Ann Rheum Dis. 2023 Oct;82(10):1286-1295. doi: 10.1136/ard-2023-224116. Epub 2023 Jul 9. Ann Rheum Dis. 2023. PMID: 37423647 Clinical Trial.
Correlation of Professional Antigen-Presenting Tbet+CD11c+ B Cells With Bone Destruction in Untreated Rheumatoid Arthritis.
McGrath S, Grimstad K, Thorarinsdottir K, Forslind K, Glinatsi D, Leu Agelii M, Aranburu A, Sundell T, Jonsson CA, Camponeschi A, Hultgård Ekwall AK, Tilevik A, Gjertsson I, Mårtensson IL. McGrath S, et al. Among authors: glinatsi d. Arthritis Rheumatol. 2024 Aug;76(8):1263-1277. doi: 10.1002/art.42857. Epub 2024 May 21. Arthritis Rheumatol. 2024. PMID: 38570939
Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission: 5-year follow-up of the IMAGINE-RA randomised trial.
Møller-Bisgaard S, Hørslev-Petersen K, Ørnbjerg LM, Ejbjerg B, Hetland ML, Møller JM, Nielsen SM, Glinatsi D, Boesen M, Stengaard-Pedersen K, Madsen OR, Jensen B, Villadsen JA, Hauge EM, Hendricks O, Lindegaard H, Krogh NS, Jurik AG, Thomsen H, Christensen R, Østergaard M. Møller-Bisgaard S, et al. Among authors: glinatsi d. RMD Open. 2024 Mar 15;10(1):e003945. doi: 10.1136/rmdopen-2023-003945. RMD Open. 2024. PMID: 38490697 Free PMC article. Clinical Trial.
The OMERACT MRI in Arthritis Working Group - Update on Status and Future Research Priorities.
Østergaard M, Bird P, Gandjbakhch F, Eshed I, Haugen IK, Haavardsholm EA, Lillegraven S, Foltz V, Glinatsi D, Peterfy C, Ejbjerg B, Bøyesen P, Mease PJ, Hermann KG, Emery P, Genant HK, Conaghan PG. Østergaard M, et al. Among authors: glinatsi d. J Rheumatol. 2015 Dec;42(12):2470-2. doi: 10.3899/jrheum.141248. Epub 2015 Feb 15. J Rheumatol. 2015. PMID: 25684771 Review.
Atlas of the OMERACT Heel Enthesitis MRI Scoring System (HEMRIS).
Mathew AJ, Krabbe S, Eshed I, Lambert RG, Laredo JD, Maksymowych WP, Gandjbakhch F, Emad Y, Stoenoiu MS, Foltz V, Bird P, Carron P, Paschke J, Conaghan PG, Pedersen SJ, Glinatsi D, Østergaard M. Mathew AJ, et al. Among authors: glinatsi d. RMD Open. 2020 Feb;6(1):e001150. doi: 10.1136/rmdopen-2019-001150. Epub 2020 Feb 11. RMD Open. 2020. PMID: 32568094 Free PMC article.
Radiographic airway abnormalities in untreated early rheumatoid arthritis are associated with peripheral neutrophil activation.
Selldén T, Mårdh CK, Joelsson M, Vikgren J, Johnsson Å, Larsson G, Glinatsi D, Stubendorff K, Svensson K, Gjertsson I, Rudin A, Lundell AC, Ekwall AH. Selldén T, et al. Among authors: glinatsi d. Arthritis Res Ther. 2023 Mar 20;25(1):44. doi: 10.1186/s13075-023-03019-5. Arthritis Res Ther. 2023. PMID: 36941690 Free PMC article.
Doppler ultrasound predicts successful discontinuation of biological DMARDs in rheumatoid arthritis patients in clinical remission.
Terslev L, Brahe CH, Hetland ML, Georgiadis S, Ellegaard K, Juul L, Huynh T, Døhn UM, Fana V, Møller T, Krabbe S, Ørnbjerg LM, Glinatsi D, Røgind H, Hansen A, Nørregaard J, Jacobsen S, Jensen DV, Manilo N, Asmussen K, Boesen M, Rastiemadabadi Z, Morsel-Carlsen L, Møller JM, Krogh NS, Østergaard M. Terslev L, et al. Among authors: glinatsi d. Rheumatology (Oxford). 2021 Dec 1;60(12):5549-5559. doi: 10.1093/rheumatology/keab276. Rheumatology (Oxford). 2021. PMID: 33748831
Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictors.
Terslev L, Ostergaard M, Georgiadis S, Brahe CH, Ellegaard K, Dohn UM, Fana V, Møller T, Juul L, Huynh TK, Krabbe S, Ornbjerg LM, Glinatsi D, Røgind H, Hansen A, Nørregaard J, Jacobsen S, Jensen DV, Manilo N, Asmussen K, Boesen M, Rastiemadabadi Z, Morsel-Carlsen L, Møller JM, Krogh NS, Hetland ML. Terslev L, et al. Among authors: glinatsi d. RMD Open. 2022 Dec;8(2):e002796. doi: 10.1136/rmdopen-2022-002796. RMD Open. 2022. PMID: 36549857 Free PMC article.
29 results